Biomarkers for Alzheimer’s Disease Drug Development
| Körperschaft: | |
|---|---|
| Weitere Verfasser: | |
| Zusammenfassung: | XII, 347 p. 51 illus., 49 illus. in color. text |
| Sprache: | Englisch |
| Veröffentlicht: |
New York, NY :
Springer US : Imprint: Humana,
2024.
|
| Ausgabe: | 2nd ed. 2024. |
| Schriftenreihe: | Methods in Molecular Biology,
2785 |
| Schlagworte: | |
| Online-Zugang: | https://doi.org/10.1007/978-1-0716-3774-6 |
| Format: | Elektronisch E-Book |
Inhaltsangabe:
- Blood-Based Biomarkers for Early Alzheimer’s Disease Diagnosis in Real-World Settings
- Alzheimer’s Disease Prevention and Treatment Based on Population-Based Approaches
- CSF N-Glycomics Using High Throughput UPLC-ESI Techniques in Alzheimer’s Disease
- CSF N-Glycomics Using MALDI MS Techniques
- Optimized Pre-Analytical Handling Protocol for Blood-Based Biomarkers of Alzheimer’s Disease
- Mass Spectrometry-Based Metabolomics Multi-Platform for Alzheimer’s Disease Research
- Analysis of Resting-State Functional Magnetic Resonance Imaging in Alzheimer's Disease
- Diffusion Tensor Imaging in Alzheimer’s Studies
- Magnetic Resonance Spectroscopy (MRS) in Alzheimer’s Disease
- Neuroimaging Methods for MRI Analysis in CSF Biomarkers Studies
- Amyloid PET Imaging: Standard Procedures and Semiquantification
- PET Imaging to Measure Neuroinflammation In Vivo
- Imaging Neuroinflammation: Quantification of Astrocytosis in a Multitracer PET Approach
- High-Throughput Lipidomics and Metabolomics Profiling for Brain Tissue and Biofluid Samples in Neurodegenerative Disorders
- Neuropathological Assessment as an Endpoint in Clinical Trial Design
- Non-Invasive Visualization of Amyloid-Beta Deposits in Alzheimer’s Amyloidosis Mice via Fluorescence Molecular Tomography Using Contrast Agent
- Brain Banking in Dementia Studies
- Speech-Based Digital Biomarkers for Alzheimer’s Research
- cCOG Web-Based Cognitive Assessment Tool
- In Silico Models to Validate Novel Blood-Based Biomarkers.